StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report released on Tuesday. Separately, Wedbush reissued an outperform rating and issued a $5.00 target price on shares of Adicet Bio in a report on Thursday, January 4th. One equities research analyst has rated the stock with a […]
StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report released on Tuesday. Separately, Wedbush reissued an outperform rating and issued a $5.00 target price on shares of Adicet Bio in a report on Thursday, January 4th. One equities research analyst has rated the stock with a […]
Stock Analysts’ upgrades for Tuesday, January 9th: Adicet Bio (NASDAQ:ACET) was upgraded by analysts at StockNews.com to a sell rating. Akamai Technologies (NASDAQ:AKAM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Catalent (NYSE:CTLT) was upgraded by analysts at StockNews.com to a sell rating. Central Valley Community Bancorp (NASDAQ:CVCY) was […]
Adicet Bio, Inc. (NASDAQ:ACET – Free Report) – Stock analysts at Wedbush issued their FY2028 earnings per share (EPS) estimates for Adicet Bio in a research note issued to investors on Thursday, January 4th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($1.16) for the year. Wedbush has a […]